Ahmed Ali Chughtai

Dr. Ahmed Ali Chughtai

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in PeerJ
Verified
Journal Article
Open access
PDF file
ACAhmed Ali Chughtai
Ahmed Ali Chughtai
FKFilip Kaššák
Filip Kaššák
MKMarkéta Kostrouchová
Markéta Kostrouchová
JNJan Philipp Novotný
Jan Philipp Novotný
MKMichael W. Krause
Michael W. Krause
ZKZdenek Kostrouch
Zdenek Kostrouch
Perilipins are lipid droplet surface proteins that contribute to fat metabolism by controlling the access of lipids to lipolytic enzymes. Perilipins have been identified in organisms as diverse as metazoa, fungi, and amoebas but strikingly not in nematodes. Here we identify the protein encoded by the W01A8.1 gene in Caenorhabditis elegans as the closest homologue and likely orthologue of metazoan perilipin. We demonstrate that nematode W01A8.1 is a cytoplasmic protein residing on lipid droplets similarly as human perilipins 1 and 2. Downregulation or elimination of W01A8.1 affects the appearance of lipid droplets resulting in the formation of large lipid droplets localized around the dividing nucleus during the early zygotic divisions. Visualization of lipid containing structures by CARS microscopy in vivo showed that lipid-containing structures become gradually enlarged during oogenesis and relocate during the first zygotic division around the dividing nucleus. In mutant embryos, the lipid containing structures show defective intracellular distribution in subsequent embryonic divisions and become gradually smaller during further development. In contrast to embryos, lipid-containing structures in enterocytes and in epidermal cells of adult animals are smaller in mutants than in wild type animals. Our results demonstrate the existence of a perilipin-related regulation of fat metabolism in nematodes and provide new possibilities for functional studies of lipid metabolism.

1 October 2014 in Journal of Proteomics
Verified
Journal Article
Closed access
DKDavid Kostrouch
David Kostrouch
MKMarkéta Kostrouchová
Markéta Kostrouchová
PYPetr Yilma
Petr Yilma
ACAhmed Ali Chughtai
Ahmed Ali Chughtai
JNJan Philipp Novotný
Jan Philipp Novotný
ZKZdeněk Kostrouch
Zdeněk Kostrouch

30 May 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
ACAhmed Ali Chughtai
Ahmed Ali Chughtai
JPJulia Pannhausen
Julia Pannhausen
PDPia Dinger
Pia Dinger
JWJulia Wirtz
Julia Wirtz
RKRuth Knüchel-Clarke
Ruth Knüchel-Clarke
MRMichael Rose
Michael Rose
This study aims at analyzing the impact of the pharmacological inhibition of DNA damage response (DDR) targets (DNA-PK and ATR) on radiosensitization of bladder cancer cell lines of different molecular/histological subtypes. Applying DNA-PK (AZD7648) and ATR (Ceralasertib) inhibitors on SCaBER, J82 and VMCUB-1 bladder cancer cell lines, we revealed sensitization upon ionizing radiation (IR), i.e., the IC50 for each drug shifted to a lower drug concentration with increased IR doses. In line with this, drug exposure retarded DNA repair after IR-induced DNA damage visualized by a neutral comet assay. Western blot analyses confirmed specific inhibition of targeted DDR pathways in the analyzed bladder cancer cell lines, i.e., drugs blocked DNA-PK phosphorylation at Ser2056 and the ATR downstream mediator CHK1 at Ser317. Interestingly, clonogenic survival assays indicated a cell-line-dependent synergism of combined DDR inhibition upon IR. Calculating combined index (CI) values, with and without IR, according to the Chou–Talalay method, confirmed drug- and IR-dose-specific synergistic CI values. Thus, we provide functional evidence that DNA-PK and ATR inhibitors specifically target corresponding DDR pathways retarding the DNA repair process at nano-molar concentrations. This, in turn, leads to a strong radiosensitizing effect and impairs the survival of bladder cancer cells.

6 June 2017 in PeerJ
Verified
Journal Article
Open access
PDF file
MKMarkéta Kostrouchová
Markéta Kostrouchová
DKDavid Kostrouch
David Kostrouch
ACAhmed Ali Chughtai
Ahmed Ali Chughtai
FKFilip Kaššák
Filip Kaššák
JNJan P Novotný
Jan P Novotný
ZKZdeněk Kostrouch
Zdeněk Kostrouch
The evolutionarily conserved Mediator complex is a critical player in regulating transcription. Comprised of approximately two dozen proteins, the Mediator integrates diverse regulatory signals through direct protein-protein interactions that, in turn, modulate the influence of Mediator on RNA Polymerase II activity. One Mediator subunit, MED28, is known to interact with cytoplasmic structural proteins, providing a potential direct link between cytoplasmic dynamics and the control of gene transcription. Although identified in many animals and plants, MED28 is not present in yeast; no bona fide MED28 has been described previously inCaenorhabditis elegans.Here, we identify bioinformatically F28F8.5, an uncharacterized predicted protein, as the nematode homologue of MED28. As in other Metazoa, F28F8.5 has dual nuclear and cytoplasmic localization and plays critical roles in the regulation of development.F28F8.5is a vital gene and its null mutants have severely malformed gonads and do not reproduce. F28F8.5 interacts on the protein level with the Mediator subunits MDT-6 and MDT-30. Our results indicate that F28F8.5 is an orthologue of MED28 and suggest that the potential to link cytoplasmic and nuclear events is conserved between MED28 vertebrate and nematode orthologues.

25 April 2017 in PeerJ Preprints
Verified
Preprint
Open access
PDF file
JNJan Philipp Novotný
Jan Philipp Novotný
ACAhmed Ali Chughtai
Ahmed Ali Chughtai
MKMarkéta Kostrouchová
Markéta Kostrouchová
VKVeronika Kostrouchová
Veronika Kostrouchová
DKDavid Kostrouch
David Kostrouch
ZKZdenek Kostrouch
Zdenek Kostrouch
Trichoplax adhaerens, the only known species of Placozoa is likely to be closely related to an early metazoan that preceded branching of Cnidaria and Bilateria. This animal species is surprisingly well adapted to free life in the World Ocean inhabiting tidal costal zones of oceans and seas with warm to moderate temperatures and shallow waters. The genome of T. adhaerens (sp. Grell) includes four nuclear receptors, namely homologues of RXR (NR2B), HNF4 (NR2A), COUP (NR2F) and ERR (NR3B) that show a high degree of similarity with human homologues. In the case of RXR, the sequence identity to human RXR alpha reaches 81% in the DNA binding domain and 70 % in the ligand binding domain. We show that T. adhaerens RXR (TaRXR) binds 9-cis retinoic acid (9-cis-RA) with high affinity, as well as high specificity and that exposure of T. adhaerens to 9-cis-RA regulates the expression of the putative T. adhaerens homologue of vertebrate L-malate-NADP+ oxidoreductase (EC 1.1.1.40) which in vertebrates is regulated by a heterodimer of RXR and thyroid hormone receptor. Treatment by 9-cis-RA alters the relative expression profile of T. adhaerens nuclear receptors, suggesting the existence of natural ligands. Keeping with this, algal food composition has profound effect on T. adhaerens growth and appearance. Our results uncover an endocrine-like network of nuclear receptors sensitive to 9-cis-RA in T. adhaerens and support the existence of a ligand-sensitive network of nuclear receptors at the base of metazoan evolution.

15 December 2025 in Technical Innovations & Patient Support in Radiation Oncology
Verified
Journal Article
Open access
BSBiney Pal Singh
Biney Pal Singh
ACAhmed Ali Chughtai
Ahmed Ali Chughtai
JSJennifer Stock
Jennifer Stock
PBPhilipp Bruners
Philipp Bruners
MEMichael J. Eble
Michael J. Eble
AMAhmed Allam Mohamed
Ahmed Allam Mohamed
Radiation therapy (RT) plays a central role in the treatment of lung cancer. However, cardiac and pulmonary toxicities remain major concerns. Deep inspiration breath-hold (DIBH) has been shown to improve target stability and reduce organ-at-risk (OAR) exposure, but data in lung cancer, particularly regarding cardiac substructures, remain limited. We retrospectively analysed 32 patients with lung cancer treated with RT at our institution between 2020 and 2021. Each patient underwent planning CTs in both DIBH and free breathing (FB), generating a total of 64 treatment plans using VMAT (60 Gy in 30 fractions). Contouring followed ESTRO ACROP guidelines, including detailed segmentation of cardiac chambers and coronary arteries. Dosimetric endpoints included Dmean, D2%, and VxGy for lung, heart, and subcardiac structures. Statistical comparisons between DIBH and FB plans were performed. DIBH significantly increased lung volume and improved all lung dosimetric parameters, including Dmean (13.13 vs. 14.49 Gy, p < 0.001) and V20Gy (24.37 % vs. 27.28 %, p < 0.001). Cardiac sparing was evident, with lower heart D2% (39.91 vs. 41.67 Gy, p = 0.012) and V45Gy (2.23 % vs. 2.53 %, p = 0.005). Notably, significant reductions were observed in the LAD (Dmean: 5.59 vs. 6.57 Gy, p = 0.004), LCX, and LV. Subgroup analyses demonstrated consistent dosimetric advantages across tumor laterality and level 7 nodal involvement. DIBH offers substantial and consistent dosimetric benefits in lung cancer RT, reducing radiation burden to pulmonary, cardiac, and coronary structures. Given the known association between cardiac dose and long-term morbidity, these findings support the broader implementation of DIBH, especially in anatomically challenging cases involving subcarinal nodes or left-sided tumors.